Showing results (271-280 of 672) with videos related to
Sort By:
Pageof 68
Studies in Health Technology and Informatics|May 27, 2021
A Wide Database for Future Studies Aimed at Improving Early Recognition of CandidemiaSara Mora, Daniele Roberto Giacobbe, Chiara Russo, et al.Expert Opinion on Pharmacotherapy|December 9, 2021
Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumoniaMatteo Bassetti, Laura Labate, Monica Melchio, et al.Mycoses|August 8, 2022
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesisDaniele Roberto Giacobbe, Erika Asperges, Andrea Cortegiani, et al.The Journal of Antimicrobial Chemotherapy|February 25, 2005
Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patientsMario Cruciani, Giorgio Gatti, Emanuela Vaccher, et al.Jac-Antimicrobial Resistance|September 16, 2022
Early appropriate diagnostics and treatment of MDR Gram-negative infectionsMatteo Bassetti, Souha S Kanj, Pattarachai Kiratisin, et al.Current Opinion in Infectious Diseases|February 19, 2020
The interplay between acute bacterial skin and skin structure infections and depression: a vicious circle of major clinical importanceMatteo Bassetti, Benito Almirante, Evangelos J Giamarellos-Bourboulis, et al.Annals of Medicine|March 1, 2023
Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decadesDaniele Roberto Giacobbe, Vincenzo Di Pilato, Ilias Karaiskos, et al.Frontiers in Bioscience (Landmark Edition)|September 30, 2021
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenarioDaniele Roberto Giacobbe, Lorenzo Ball, Laura Magnasco, et al.Future Microbiology|November 3, 2020
Treatment of severe infections due to metallo-β-lactamases-producing Gram-negative bacteriaMatteo Bassetti, Vincenzo Di Pilato, Tommaso Giani, et al.Infectious Diseases and Therapy|April 11, 2025
Meropenem-Vaborbactam for Treatment of Carbapenem-Resistant Enterobacterales: A Narrative Review of Clinical Practice EvidenceMatteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, et al.Pageof 68